Fructooligosaccharides (FOS) için Chronic Constipation

Q: Does Fructooligosaccharides (FOS) help with Chronic Constipation?

Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).

Q: How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?

We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Sonuç

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Key Study Findings

Review

Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.

Dose: None vs: None Outcome: gut health outcomes including microbiota modulation and SCFA … Etki: None None

Popülasyon: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis

Randomized Controlled Trial n=67 4 weeks Double-blind

Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …

Dose: None vs: Placebo Outcome: Weekly spontaneous bowel movements Etki: 4.94 vs 3.00 (P<0.001) P<0.001

Popülasyon: Older adults >=60 with functional constipation (Rome IV)

Other

Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …

Dose: 2 g vs: None Outcome: Constipation symptoms Etki: None P < 0.05

Popülasyon: Constipation patients

Randomized Controlled Trial Double-blind

Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.

Dose: 6 g vs: Placebo Outcome: Constipation symptoms Etki: None None

Popülasyon: Constipation patients

Systematic Review

Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Dose: None vs: None Outcome: Constipation symptoms Etki: OR: 10.36 p < 0.00001

Popülasyon: Constipation patients

Randomized Controlled Trial Double-blind

Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.

Dose: None vs: Placebo Outcome: Constipation symptoms Etki: None None

Popülasyon: Constipation patients

Key Statistics

Çalışmalar

350

Katılımcılar

↑

Positive

Derece

Referenced Papers

Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions. Review

Nutrients 2026 1 atıf

Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, … RCT

The journal of … 2025

Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium. Other

Food science & … 2024 17 atıf

Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Review

Foods (Basel, Switzerland) 2024 8 atıf

Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics. Review

Journal of Parkinson's … 2024 4 atıf

Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned piglets. Other

Animal nutrition (Zhongguo … 2024 4 atıf

Inulin as a functional ingredient and their applications in meat products. Review

Carbohydrate polymers 2022 77 atıf

In vitro Study of Bifidobacterium lactis BL-99 With Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota. Other

Frontiers in nutrition 2022 22 atıf

Effects of β-Fructans Fiber on Bowel Function: A Systematic Review and Meta-Analysis. Meta-Analysis

Nutrients 2019 35 atıf

Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation. RCT

Nutrients 2018 30 atıf

Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and … Review

Journal of the … 2017 447 atıf

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double … RCT

Neurogastroenterology and motility 2017 131 atıf

Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month. RCT

Nutrients 2017 28 atıf

Effectiveness of nutritional treatment and synbiotic use on gastrointestinal symptoms reduction in HIV-infected patients: Randomized clinical trial. RCT

Clinical nutrition (Edinburgh, … 2017 20 atıf

Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients. RCT

Peritoneal dialysis international … 2016 38 atıf

Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review. Review

World journal of … 2014 16 atıf

Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response. RCT

Clinical nutrition (Edinburgh, … 2013

Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents--a placebo-controlled, diet-controlled trial. CCT

Nutrition (Burbank, Los … 2011 65 atıf

Beneficial effects of a synbiotic supplement on self-perceived gastrointestinal well-being and immunoinflammatory status of healthy adults. RCT

Journal of medicinal … 2011 24 atıf

Dietary fructooligosaccharides and potential benefits on health. Review

Journal of physiology … 2009 312 atıf

Constipation in long-term care. Review

Journal of the … 2007 84 atıf

Novel physiological function of fructooligosaccharides. Review

BioFactors (Oxford, England) 2004 48 atıf

Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial. RCT

The British journal … 2003 97 atıf

Safety and tolerance of medical nutritional products as sole sources of nutrition in people on hemodialysis. RCT

Journal of renal … 1998 71 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:: 2-10 g/day
prebioticeffect:: 5-8 g/day for bifidogenic effect
constipationsupport:: 5-10 g/day

Üst sınır: Well-tolerated up to 20 g/day; start low to avoid excess gas

Araştırmalarda İncelenen Dozajlar

Dozaj	Süre	Etki	N
None	--	Positive	--
None	4 weeks	Positive	67
2 g	--	Neutral	--
6 g	--	Positive	--
None	--	Positive	--
None	--	Positive	--
None	--	Mixed	--
None	--	Positive	--

En iyi alım zamanı: With meals; divide doses throughout the day

Safety & Side Effects

Bildirilen Yan Etkiler

⚠ Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
⚠ Abdominal cramping at higher doses
⚠ May worsen IBS symptoms in FODMAP-sensitive individuals
⚠ Loose stools at excessive doses

Bilinen Etkileşimler

● Other FODMAPs (cumulative fermentation effect in sensitive individuals)
● Blood sugar-lowering medications (FOS may modestly affect glycemic response)
● Calcium supplements (FOS may enhance calcium absorption)

Tolere edilebilir üst alım: Well-tolerated up to 20 g/day; start low to avoid excess gas

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Chronic Constipation?

Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).

How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?

We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

Şu durum için diğer içerikler: Chronic Constipation

Psyllium Husk A Inulin B Bifidobacterium lactis B

Fructooligosaccharides (FOS) diğer sağlık durumları için

Irritable Bowel Syndrome (IBS) D

Hızlı Değerlendirme

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Evidence Strength52%

Moderate confidence

Çalışma Dağılımı

RCT (10)Meta (1)Other (0)

Alternatifleri Karşılaştır

Bu durum için diğer bileşenlerin nasıl karşılaştırıldığını görün.Diğer içeriklerin bu sağlık durumu için nasıl karşılaştırıldığını görün.

Şu durum için tüm içerikleri görüntüle: Chronic Constipation

Daha Fazla Bilgi

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.